New Method for Treating Alzheimer's Disease
Scientists from Harvard Medical School have found that people with mild cognitive impairment and a diagnosis of Alzheimer's have significantly lower levels of lithium in their brains. This discovery could change the approach to treating a disease that currently affects more than 55 million people worldwide.
Experiments conducted on mice given lithium orotate showed impressive results: animals that had lost their ability to remember began to successfully complete memory tests, and there was also a reduction in amyloid plaques and pathological tau proteins in their brains.
"The idea that lithium deficiency could be the cause of Alzheimer's is new and opens up another therapeutic approach," emphasized Professor Yankner.
Experts believe that lithium orotate has two key advantages: it delivers better to brain cells than traditional forms of lithium and does not require large doses, reducing the risk of toxicity. Professor Matt Kaeberlein from the University of Washington believes that the next step should be to conduct randomized studies.
Research has shown that lithium deficiency may be significant for the development of Alzheimer's disease, and the use of lithium orotate may be a promising direction for further research and the development of new treatment methods for this dangerous disease.